Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CT Perfusion in the Prognostication of Cerebral High Grade Glioma

NCT01923922 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT01923922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CT Perfusion in the Prognostication of Cerebral High Grade Glioma
Lead sponsor
Nova Scotia Health Authority
Phase
Not applicable
Overall status
Completed
Start date
September 9, 2013
Completion date
October 22, 2019
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme